Effect of Wenxia Changfu Formula Combined With Cisplatin Reversing Non-Small Cell Lung Cancer Cell Adhesion-Mediated Drug Resistance.

Wang, Meng-Ran; Chen, Rui-Jie; Zhao, Fang; Zhang, Hong-Hua; Bi, Qian-Yu; Zhang, Ya-Nan; Zhang, Yin-Qiang; Wu, Zhi-Chun; Ji, Xu-Ming

Wang, Meng-Ran; Chen, Rui-Jie; Zhao, Fang; Zhang, Hong-Hua; Bi, Qian-Yu; Zhang, Ya-Nan; Zhang, Yin-Qiang; Wu, Zhi-Chun; Ji, Xu-Ming.

Afiliação

Wang MR; School of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China.
Chen RJ; School of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China.
Zhao F; School of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China.
Zhang HH; Medical College, Hangzhou Normal University, Hangzhou, China.
Bi QY; College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Zhang YN; College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Zhang YQ; Department of Hepatic Diseases, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Wu ZC; College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Ji XM; School of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China.

Front Pharmacol ; 11: 500137, 2020.

Article em En | MEDLINE | ID: mdl-33041787

Palavras-chave

Wenxia Changfu Formula; cell adhesion-mediated drug resistance; colocalization; integrin ß1; lung adenocarcinoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google